814 related articles for article (PubMed ID: 33096794)
1. Advances in the Treatment and Prevention of Chemotherapy-Induced Ovarian Toxicity.
Cho HW; Lee S; Min KJ; Hong JH; Song JY; Lee JK; Lee NW; Kim T
Int J Mol Sci; 2020 Oct; 21(20):. PubMed ID: 33096794
[TBL] [Abstract][Full Text] [Related]
2. Current and Future Perspectives for Improving Ovarian Tissue Cryopreservation and Transplantation Outcomes for Cancer Patients.
Lee S; Ozkavukcu S; Ku SY
Reprod Sci; 2021 Jun; 28(6):1746-1758. PubMed ID: 33791995
[TBL] [Abstract][Full Text] [Related]
3. Molecular Mechanism and Prevention Strategy of Chemotherapy- and Radiotherapy-Induced Ovarian Damage.
Kim S; Kim SW; Han SJ; Lee S; Park HT; Song JY; Kim T
Int J Mol Sci; 2021 Jul; 22(14):. PubMed ID: 34299104
[TBL] [Abstract][Full Text] [Related]
4. The Impact of Chemotherapy on the Ovaries: Molecular Aspects and the Prevention of Ovarian Damage.
Sonigo C; Beau I; Binart N; Grynberg M
Int J Mol Sci; 2019 Oct; 20(21):. PubMed ID: 31717833
[TBL] [Abstract][Full Text] [Related]
5. In vitro maturation of human immature oocytes for fertility preservation.
Chian RC; Uzelac PS; Nargund G
Fertil Steril; 2013 Apr; 99(5):1173-81. PubMed ID: 23433515
[TBL] [Abstract][Full Text] [Related]
6. [Oncofertility and breast cancer].
Sonigo C; Grynberg M; Bringer S; Sermondade N
Bull Cancer; 2019 Dec; 106(12S1):S43-S52. PubMed ID: 32008738
[TBL] [Abstract][Full Text] [Related]
7. Fertility after breast cancer treatment.
Kasum M; Beketić-Orešković L; Peddi PF; Orešković S; Johnson RH
Eur J Obstet Gynecol Reprod Biol; 2014 Feb; 173():13-8. PubMed ID: 24315568
[TBL] [Abstract][Full Text] [Related]
8. Present and future fertility preservation strategies for female cancer patients.
Georgescu ES; Goldberg JM; du Plessis SS; Agarwal A
Obstet Gynecol Surv; 2008 Nov; 63(11):725-32. PubMed ID: 18928577
[TBL] [Abstract][Full Text] [Related]
9. New trends in female fertility preservation: in vitro maturation of oocytes.
Berwanger AL; Finet A; El Hachem H; le Parco S; Hesters L; Grynberg M
Future Oncol; 2012 Dec; 8(12):1567-73. PubMed ID: 23231518
[TBL] [Abstract][Full Text] [Related]
10. [Fertility preservation techniques in women of reproductive age ].
Vulliemoz N ; Gaitzsch H ; Primi M-P ; Wunder D ; Perey L ; Streuli I
Rev Med Suisse; 2014 Oct; 10(447):1961-2, 1964-6, 1968. PubMed ID: 25518205
[TBL] [Abstract][Full Text] [Related]
11. Fertility preservation options in breast cancer patients.
Kasum M; von Wolff M; Franulić D; Čehić E; Klepac-Pulanić T; Orešković S; Juras J
Gynecol Endocrinol; 2015; 31(11):846-51. PubMed ID: 26370157
[TBL] [Abstract][Full Text] [Related]
12. Cryopreservation of Oocytes Retrieved from Ovarian Tissue to Optimize Fertility Preservation in Prepubertal Girls and Women.
Brouillet S; Ferrieres-Hoa A; Fournier A; Martinez G; Bessonnat J; Gueniffey A; Gala A; Loup V; Hamamah S
J Vis Exp; 2020 Oct; (164):. PubMed ID: 33165323
[TBL] [Abstract][Full Text] [Related]
13. Cryopreservation of in vitro matured oocytes in addition to ovarian tissue freezing for fertility preservation in paediatric female cancer patients before and after cancer therapy.
Abir R; Ben-Aharon I; Garor R; Yaniv I; Ash S; Stemmer SM; Ben-Haroush A; Freud E; Kravarusic D; Sapir O; Fisch B
Hum Reprod; 2016 Apr; 31(4):750-62. PubMed ID: 26848188
[TBL] [Abstract][Full Text] [Related]
14. Strategies for fertility preservation in young early breast cancer patients.
Tomasi-Cont N; Lambertini M; Hulsbosch S; Peccatori AF; Amant F
Breast; 2014 Oct; 23(5):503-10. PubMed ID: 24934638
[TBL] [Abstract][Full Text] [Related]
15. [Fertility preservation strategies in young women in case of breast cancer or hematologic malignancy].
Decanter C; Robin G
Gynecol Obstet Fertil; 2013 Oct; 41(10):597-600. PubMed ID: 24094596
[TBL] [Abstract][Full Text] [Related]
16. [Fertility preservation in women of the childbearing age: Indications and strategies].
Bénard J; Calvo J; Comtet M; Benoit A; Sifer C; Grynberg M
J Gynecol Obstet Biol Reprod (Paris); 2016 May; 45(5):424-44. PubMed ID: 27021926
[TBL] [Abstract][Full Text] [Related]
17. Fertility preservation options for women with malignancies.
Marhhom E; Cohen I
Obstet Gynecol Surv; 2007 Jan; 62(1):58-72. PubMed ID: 17176489
[TBL] [Abstract][Full Text] [Related]
18. Ovarian Tissue Oocyte-In Vitro Maturation for Fertility Preservation.
Segers I; Mateizel I; Wouters K; Van Moer E; Anckaert E; De Munck N; De Vos M
J Vis Exp; 2024 May; (207):. PubMed ID: 38829044
[TBL] [Abstract][Full Text] [Related]
19. THERAPY OF ENDOCRINE DISEASE: Novel protection and treatment strategies for chemotherapy-associated ovarian damage.
Xiong J; Xue L; Li Y; Tang W; Chen D; Zhang J; Dai J; Zhou S; Lu Z; Wu M; Wang S
Eur J Endocrinol; 2021 May; 184(5):R177-R192. PubMed ID: 33630753
[TBL] [Abstract][Full Text] [Related]
20. Random Start Ovarian Stimulation for Oocyte or Embryo Cryopreservation in Women Desiring Fertility Preservation Prior to Gonadotoxic Cancer Therapy.
Danis RB; Pereira N; Elias RT
Curr Pharm Biotechnol; 2017 Nov; 18(8):609-613. PubMed ID: 28786354
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]